What is a 'failure' of bisphosphonate therapy for osteoporosis?

John J. Carey, MD
Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: John J. Carey, MD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Carey has indicated that he has received grant or research support from the Proctor and Gamble corporation, serves as a consultant for Eli Lilly and Company, and is on the speaker’s bureau of Proctor and Gamble.

John J. Carey, MD
Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: John J. Carey, MD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Carey has indicated that he has received grant or research support from the Proctor and Gamble corporation, serves as a consultant for Eli Lilly and Company, and is on the speaker’s bureau of Proctor and Gamble.

John J. Carey, MD
Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: John J. Carey, MD, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Carey has indicated that he has received grant or research support from the Proctor and Gamble corporation, serves as a consultant for Eli Lilly and Company, and is on the speaker’s bureau of Proctor and Gamble.